Elevance Health, Inc. (ELV) reported third-quarter 2024 adjusted earnings per share (EPS) of $8.37, which lagged the Zacks Consensus Estimate by 13.7%. The bottom line deteriorated 6.9% year over year. Operating revenues of $44.7 billion rose 5.2% year over year. Moreover, the top line beat the consensus mark by 3.4%. Quarterly earnings were impacted by rising expenses and a decline in Medicaid and Medicare membership. However, improved product revenues in the CarelonRx business and better premiums in the H ...

Elevance Health Inc. ELV reported on Thursday third-quarter revenues of $44.7 billion, up 5.3% year-overyear, beating the consensus of $43.33 billion. The increase was driven by higher premium yields in the Health Benefits segment and growth in CarelonRx product revenue, partially offset by membership attrition in the Medicaid business. The benefit expense ratio was 89.5%, an increase of 270 basis points, driven primarily by the timing mismatch between Medicaid rates and the higher acuity of members. The co ...

Elevance Health, Inc. (NYSE:ELV) Q3 2024 Results Conference Call October 17, 2024 8:30 AM ET Company Participants Steve Tanal - Vice President of Investor Relations Gail Boudreaux - President and CEO Mark Kaye - CFO Pete Haytaian - President, Carelon Morgan Kendrick - President, Commercial Health Benefits Felicia Norwood - President, Government Health Benefits Conference Call Participants A.J. Rice - UBS Stephen Baxter - Wells Fargo Ben Hendrix - RBC Capital Markets Ann Hynes - Mizuho Erin Wright - Morgan S ...

Key Takeaways Elevance Health shares plunged Thursday after the insurer reported lower-than-expected earnings and cut its outlook as changes in Medicaid slashed membership rolls. The insurer's third-quarter Medicaid membership dropped 19% from a year ago on eligibility redeterminations and other changes to the program. Elevance said because of the issues with Medicaid, it lowered its full-year profit outlook. Elevance Health (ELV) shares cratered Thursday after the insurer posted a lower-than-expected profi ...

For the quarter ended September 2024, Elevance Health (ELV) reported revenue of $44.72 billion, up 5.3% over the same period last year. EPS came in at $8.37, compared to $8.99 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $43.26 billion, representing a surprise of +3.37%. The company delivered an EPS surprise of -13.71%, with the consensus EPS estimate being $9.70. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...

On Thursday, Elevance Health Inc. ELV reported third-quarter revenues of $44.7 billion, up 5.3% year-overyear, beating the consensus of $43.33 billion. The increase was driven by higher premium yields in the Health Benefits segment and growth in CarelonRx product revenue, partially offset by membership attrition in the Medicaid business. The benefit expense ratio was 89.5%, an increase of 270 basis points, driven primarily by the timing mismatch between Medicaid rates and the higher acuity of members. "We r ...

Elevance Health (ELV) came out with quarterly earnings of $8.37 per share, missing the Zacks Consensus Estimate of $9.70 per share. This compares to earnings of $8.99 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -13.71%. A quarter ago, it was expected that this health insurer would post earnings of $9.99 per share when it actually produced earnings of $10.12, delivering a surprise of 1.30%. Over the last four quarters, the ...

E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS THIRD QUARTER 2024 RESULTS • 3Q 2024 operating revenue of $44.7 billion 1 • 3Q 2024 adjusted operating gain of $2.4 billion 2 1 • 3Q 2024 diluted EPS of $4.36; adjusted diluted EPS of $8.37 • 4Q 2024 dividend of $1.63 per share declared to shareholders Indianapolis, IN - October 17, 2024 - Elevance Health, Inc. (NYSE: ELV) reported third quarter 2024 results. "We remain confident in the long-term earnings potential of our diverse businesses as we navigat ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Elevance Health (ELV) , which belongs to the Zacks Medical Services industry. This health insurer has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 1.13%. For the last reported quarter, Elevance Health came out with earnings of $10.12 per share versus t ...

Elevance Health, Inc. (ELV) is set to report its third-quarter 2024 results on Oct. 17, 2024, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings and revenues is pegged at $9.74 per share and $43.2 billion, respectively. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The earnings estimate for the to-be-reported quarter has witnessed downward revisions over the past 60 days. The bottom-line projection indicates year-over-year growth of 8. ...